{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:42:31Z","timestamp":1786207351161,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19741-8","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:56:17Z","timestamp":1780300577000},"page":"7849-7858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AFP Model Predicts Outcomes After Liver Resection: A Multicenter Retrospective Cohort Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Belkacem","family":"Acidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetana","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hobeika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Allaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cauchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Salame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Scatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"issue":"6","key":"19741_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin."},{"issue":"15","key":"19741_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med."},{"issue":"1","key":"19741_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"19741_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","volume":"16","author":"N Mehta","year":"2018","unstructured":"Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, et al. Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within Milan Criteria: a multicenter study. Clin Gastroenterol Hepatol. 2018;16(6):955\u201364.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"19741_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693\u20139.","journal-title":"N Engl J Med."},{"key":"19741_CR6","first-page":"109810","volume":"190","author":"A Belkacem","year":"2025","unstructured":"Belkacem A, Mohamed G, Omar A, Nassiba B, Daniel C, Eric V, et al. Quantification of remnant liver ischemia after hepatectomy using advanced 3D-software analysis and its impact on hepatocellular carcinoma recurrence. Surgery. 2025;190:109810.","journal-title":"Surgery."},{"issue":"19","key":"19741_CR7","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","volume":"359","author":"Y Hoshida","year":"2008","unstructured":"Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008;359(19):1995\u20132004.","journal-title":"N Engl J Med."},{"issue":"2","key":"19741_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723\u201350.","journal-title":"Hepatology."},{"issue":"11","key":"19741_CR9","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","volume":"7","author":"FY Yao","year":"2007","unstructured":"Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007;7(11):2587\u201396.","journal-title":"Am J Transplant."},{"issue":"6","key":"19741_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1001\/jamasurg.2021.0954","volume":"156","author":"KJ Halazun","year":"2021","unstructured":"Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, et al. Dynamic alpha-fetoprotein response and outcomes after liver transplant for hepatocellular carcinoma. JAMA Surg. 2021;156(6):559\u201367.","journal-title":"JAMA Surg."},{"issue":"8","key":"19741_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/lt.23904","volume":"20","author":"B Hameed","year":"2014","unstructured":"Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-fetoprotein level > 1000 ng\/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014;20(8):945\u201351.","journal-title":"Liver Transpl."},{"issue":"3","key":"19741_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2016.10.038","volume":"66","author":"A Notarpaolo","year":"2017","unstructured":"Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, et al. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. J Hepatol. 2017;66(3):552\u20139.","journal-title":"J Hepatol."},{"key":"19741_CR13","doi-asserted-by":"crossref","unstructured":"Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al. Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012;143(4):986\u201394 e3; quiz e14-5.","DOI":"10.1053\/j.gastro.2012.05.052"},{"issue":"2","key":"19741_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/bjsopen\/zraf041","volume":"9","author":"C Li","year":"2025","unstructured":"Li C, Diao YK, Li YF, Lv SD, Wang XM, Wang XD, et al. alpha-Fetoprotein model versus Milan criteria in predicting outcomes after hepatic resection for hepatocellular carcinoma: multicentre study. BJS Open. 2025;9(2):41.","journal-title":"BJS Open."},{"issue":"1","key":"19741_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00000658-200007000-00003","volume":"232","author":"R Tung-Ping Poon","year":"2000","unstructured":"Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232(1):10\u201324.","journal-title":"Ann Surg."},{"issue":"20","key":"19741_CR16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med."},{"issue":"11","key":"19741_CR17","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1007\/s11605-013-2314-2","volume":"17","author":"AJ Richardson","year":"2013","unstructured":"Richardson AJ, Pang TC, Johnston E, Hollands MJ, Lam VW, Pleass HC. The volume effect in liver surgery\u2014a systematic review and meta-analysis. J Gastrointest Surg. 2013;17(11):1984\u201396.","journal-title":"J Gastrointest Surg."},{"issue":"9596","key":"19741_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet."},{"key":"19741_CR19","unstructured":"European Association for the Study of the L. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82(2):315\u201374."},{"issue":"1","key":"19741_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jhbp.1091","volume":"29","author":"G Wakabayashi","year":"2022","unstructured":"Wakabayashi G, Cherqui D, Geller DA, Abu Hilal M, Berardi G, Ciria R, et al. The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system. J Hepatobiliary Pancreat Sci. 2022;29(1):6\u201315.","journal-title":"J Hepatobiliary Pancreat Sci."},{"issue":"1","key":"19741_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11605-019-04277-y","volume":"24","author":"J Shindoh","year":"2020","unstructured":"Shindoh J, Kawamura Y, Kobayashi Y, Akuta N, Kobayashi M, Suzuki Y, et al. Time-to-interventional failure as a new surrogate measure for survival outcomes after resection of hepatocellular carcinoma. J Gastrointest Surg. 2020;24(1):50\u20137.","journal-title":"J Gastrointest Surg."},{"issue":"6","key":"19741_CR22","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.21873\/invivo.11413","volume":"32","author":"S Svobodova","year":"2018","unstructured":"Svobodova S, Karlikova M, Topolcan O, Pecen L, Pestova M, Kott O, et al. PIVKA-II as a potential new biomarker for hepatocellular carcinoma - a pilot study. In Vivo. 2018;32(6):1551\u20134.","journal-title":"In Vivo."},{"issue":"1","key":"19741_CR23","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1038\/s41598-025-02291-6","volume":"15","author":"KD Wang","year":"2025","unstructured":"Wang KD, Guan MJ, Bao ZY, Shi ZJ, Tong HH, Xiao ZQ, et al. Radiomics analysis based on dynamic contrast-enhanced MRI for predicting early recurrence after hepatectomy in hepatocellular carcinoma patients. Sci Rep. 2025;15(1):22240.","journal-title":"Sci Rep."},{"issue":"11","key":"19741_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105879","volume":"10","author":"F Salani","year":"2025","unstructured":"Salani F, Ponziani FR, Piscaglia F, Malapelle U, Daniele B, Porta C, et al. Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis. ESMO Open. 2025;10(11):105879.","journal-title":"ESMO Open."},{"issue":"3","key":"19741_CR25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137(3):850\u20135.","journal-title":"Gastroenterology."},{"issue":"3","key":"19741_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118825","volume":"10","author":"CY Hsu","year":"2015","unstructured":"Hsu CY, Liu PH, Lee YH, Hsia CY, Huang YH, Lin HC, et al. Using serum alpha-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff? PLoS One. 2015;10(3):e0118825.","journal-title":"PLoS One."},{"issue":"10515","key":"19741_CR27","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/S0140-6736(25)01720-9","volume":"406","author":"Z Wang","year":"2025","unstructured":"Wang Z, Fan J, Zhou S, Sun Y, Liang F, Ji Y, et al. Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2\/3 trial. Lancet. 2025;406(10515):2089\u201399.","journal-title":"Lancet."},{"key":"19741_CR28","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00934","volume":"9","author":"M Abdelrahim","year":"2025","unstructured":"Abdelrahim M, Mejia A, Esmail A, Barrera Gutierrez JC, Ouf M, Franses JW, et al. Feasibility of personalized and tumor-informed circulating tumor DNA assay for early recurrence detection in patients with hepatocellular carcinoma. JCO Precis Oncol. 2025;9:e2400934.","journal-title":"JCO Precis Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19741-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19741-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19741-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:48:17Z","timestamp":1786204097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19741-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19741"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19741-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,31]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jean Charles Nault - Research grants from Bayer and Ipsen.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}